CH380098A - Process for the preparation of new benzenesulfonylbenzylureas - Google Patents
Process for the preparation of new benzenesulfonylbenzylureasInfo
- Publication number
- CH380098A CH380098A CH108264A CH108264A CH380098A CH 380098 A CH380098 A CH 380098A CH 108264 A CH108264 A CH 108264A CH 108264 A CH108264 A CH 108264A CH 380098 A CH380098 A CH 380098A
- Authority
- CH
- Switzerland
- Prior art keywords
- blood sugar
- urea
- products
- process according
- hydrogen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 7
- 239000008280 blood Substances 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- TYCNEYCZTJHLJI-UHFFFAOYSA-N 1-benzyl-3-(4-methylphenyl)sulfonylurea Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NCC1=CC=CC=C1 TYCNEYCZTJHLJI-UHFFFAOYSA-N 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- BRSRNTJGTDYRFT-UHFFFAOYSA-N 2-(benzenesulfonyl)guanidine Chemical class NC(N)=NS(=O)(=O)C1=CC=CC=C1 BRSRNTJGTDYRFT-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims 4
- 241001465754 Metazoa Species 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 3
- 241000282472 Canis lupus familiaris Species 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 2
- JLRGJRBPOGGCBT-UHFFFAOYSA-N Tolbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1 JLRGJRBPOGGCBT-UHFFFAOYSA-N 0.000 claims 2
- 239000003513 alkali Substances 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 150000007530 organic bases Chemical class 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims 1
- RBXRTHONRIMTBL-UHFFFAOYSA-N 1-(4-aminophenyl)sulfonyl-3-benzylurea Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC(=O)NCC1=CC=CC=C1 RBXRTHONRIMTBL-UHFFFAOYSA-N 0.000 claims 1
- -1 4-methylbenzenesulfonyl Chemical group 0.000 claims 1
- 241000416162 Astragalus gummifer Species 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims 1
- 244000265913 Crataegus laevigata Species 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- 229940100389 Sulfonylurea Drugs 0.000 claims 1
- 229920001615 Tragacanth Polymers 0.000 claims 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 claims 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 claims 1
- RJNJWHFSKNJCTB-UHFFFAOYSA-N benzylurea Chemical compound NC(=O)NCC1=CC=CC=C1 RJNJWHFSKNJCTB-UHFFFAOYSA-N 0.000 claims 1
- 230000036765 blood level Effects 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000000973 chemotherapeutic effect Effects 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims 1
- 230000000968 intestinal effect Effects 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 231100000252 nontoxic Toxicity 0.000 claims 1
- 230000003000 nontoxic effect Effects 0.000 claims 1
- 231100000926 not very toxic Toxicity 0.000 claims 1
- 229940127017 oral antidiabetic Drugs 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 claims 1
- 239000000454 talc Substances 0.000 claims 1
- 229910052623 talc Inorganic materials 0.000 claims 1
- 235000010487 tragacanth Nutrition 0.000 claims 1
- 239000000196 tragacanth Substances 0.000 claims 1
- 229940116362 tragacanth Drugs 0.000 claims 1
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 229940125708 antidiabetic agent Drugs 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Verfahren zur Herstellung von neuen Benzolsulfonylbenzylharnstoffen
Der N-(4Methyl-benzolsulfonyD -N'-n-butyl-harn- stoff hat auf Grund seiner guten blutzuckersenkenden Eigenschaften und seiner guten Verträglichkeit als oral verabreichbares Antidiabetikum in der ärztlichen Praxis grosse Bedeutung erlangt (vgl. beispielsweise Dtsch. med. Wschr. 81 [1956], Seiten 823 bis 846 sowie 877 bis 906). Diese Präparate sowie analog gebaute Verbindungen der allgemeinen Formel
EMI1.1
worin R für Wasserstoff oder einen niedrigmolekularen Allkylrest oder Alkoxyrest steht bzw.
Verfahren zu deren Herstellung sind Gegenstand älterer eigener Patentanmeldungen. Weiterhin ist in der deutschen Patentschrift Nr. 965400 die Herstellung von Ver bindungen der allgemeinen Formel
EMI1.2
worin R die gleiche Bedeutung hat, beschrieben; die Verfahrenserzeugnisse sind ebenfalls durch eine ausserordentlich gute blutzuckersenkende Wirksamkeit ausgezeichnet.
Es wurde nun gefunden, dass auch Benzolsulfonylharnstoffe der allgemeinen Formel
EMI1.3
worin R für Wasserstoff oder einen niedrigmolekularen Alkylrest oder Alkoxyrest steht, A Wasserstoff oder einen Alkylrest mit höchstens 3 Kohlenstoffatomen und B Wasserstoff oder eine Alkyl- bzw.
Alkoxygruppe mit höchstens 3 Kohlenstoffatomen bedeuten, insbesondere der N-(4-Methyl-benzol- sulfonyl)-N'-benzyl-harnstoff, wertvolle blutzuckersenkende Eigenschaften besitzen und auf Grund ihrer tiefen und lang anhaltenden Wirkung und ihrer geringen Toxizität als oral verabreichbare Antidiabetika geeignet sind.
Gegenstand der vorliegenden Erfindung ist ein Verfahren zur Herstellung derartiger Benzolsulfonylharnstoffe.
Man erhält die Verfahrensprndukte gemäss der Erfindung, indem man Benzolsulfonylguanidine der Formel
EMI1.4
worin R, A und B die angegebene Bedeutung haben, hydrolysiert.
Process for the preparation of new benzenesulfonylbenzylureas
The N- (4Methyl-benzenesulfonyD -N'-n-butylurea has achieved great importance in medical practice as an orally administrable antidiabetic due to its good blood sugar-lowering properties and its good tolerance (cf. for example Dtsch. Med. Wschr. 81 [1956], pages 823 to 846 and 877 to 906) These preparations and analogously constructed compounds of the general formula
EMI1.1
where R is hydrogen or a low molecular weight alkyl radical or alkoxy radical or
Processes for their production are the subject of our own earlier patent applications. Furthermore, in German Patent No. 965400, the preparation of compounds of the general formula Ver
EMI1.2
wherein R has the same meaning, described; the products of the process are also distinguished by their extraordinarily good blood sugar-lowering effectiveness.
It has now been found that benzenesulfonylureas of the general formula
EMI1.3
where R is hydrogen or a low molecular weight alkyl radical or alkoxy radical, A is hydrogen or an alkyl radical with at most 3 carbon atoms and B is hydrogen or an alkyl or
Alkoxy groups with a maximum of 3 carbon atoms, in particular N- (4-methyl-benzenesulfonyl) -N'-benzylurea, have valuable blood-sugar-lowering properties and, due to their deep and long-lasting effect and their low toxicity, are suitable as orally administrable antidiabetic agents are.
The present invention relates to a process for the preparation of such benzenesulfonylureas.
The process products according to the invention are obtained by adding benzenesulfonylguanidines of the formula
EMI1.4
wherein R, A and B have the meaning given, hydrolyzed.
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEF24704A DE1076664B (en) | 1957-12-27 | 1957-12-27 | Process for the preparation of new N-benzenesulfonyl-N'-benzyl ureas |
DEF0027097 | 1958-11-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH380098A true CH380098A (en) | 1964-07-31 |
Family
ID=25974088
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH6749358A CH388287A (en) | 1957-12-27 | 1958-12-19 | Process for the preparation of new benzenesulfonylbenzylureas |
CH108364A CH380097A (en) | 1957-12-27 | 1958-12-19 | Process for the preparation of new benzenesulfonylbenzylureas |
CH108264A CH380098A (en) | 1957-12-27 | 1958-12-19 | Process for the preparation of new benzenesulfonylbenzylureas |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH6749358A CH388287A (en) | 1957-12-27 | 1958-12-19 | Process for the preparation of new benzenesulfonylbenzylureas |
CH108364A CH380097A (en) | 1957-12-27 | 1958-12-19 | Process for the preparation of new benzenesulfonylbenzylureas |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE574263A (en) |
CH (3) | CH388287A (en) |
SE (1) | SE205151C1 (en) |
-
1958
- 1958-12-19 CH CH6749358A patent/CH388287A/en unknown
- 1958-12-19 CH CH108364A patent/CH380097A/en unknown
- 1958-12-19 CH CH108264A patent/CH380098A/en unknown
- 1958-12-27 BE BE574263A patent/BE574263A/en unknown
-
1962
- 1962-02-28 SE SE223462A patent/SE205151C1/en unknown
Also Published As
Publication number | Publication date |
---|---|
SE205151C1 (en) | 1966-06-07 |
CH380097A (en) | 1964-07-31 |
BE574263A (en) | 1959-06-27 |
CH388287A (en) | 1965-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH380098A (en) | Process for the preparation of new benzenesulfonylbenzylureas | |
CH392498A (en) | Process for the production of new benzenesulfonyl-cyclohexyl-ureas | |
DE2629756C2 (en) | ||
AT226729B (en) | Process for the production of new sulfonylureas | |
AT236976B (en) | Process for the preparation of new benzenesulfonylureas | |
AT226728B (en) | Process for the production of new benzenesulfonyl-cyclohexyl-ureas | |
AT234114B (en) | Process for the preparation of new benzenesulfonylureas | |
AT236397B (en) | Process for the preparation of new azidobenzenesulfonylureas | |
AT219052B (en) | Process for the production of new sulfonylureas | |
AT226730B (en) | Process for the production of new sulfonylureas | |
CH371108A (en) | Process for the preparation of sulfonylureas | |
AT345300B (en) | PROCESS FOR THE PREPARATION OF NEW 4- (BETA-UREIDOAETHYL) -BENZENE SULFONYL UREA AND THEIR SALTS | |
CH459979A (en) | Process for the preparation of benzenesulfonylureas | |
DE2244737B2 (en) | H-o-chlorophenyD-2-tert-butylaminoethanol, process for its production and pharmaceuticals based on it | |
AT236413B (en) | Process for the preparation of new benzenesulfonylureas | |
AT216521B (en) | Process for the preparation of new benzenesulfonylureas | |
AT211310B (en) | Process for the preparation of new 2-sulfonamido-thiadiazole derivatives | |
DE1593970C3 (en) | Homoarginine polymers and processes for their preparation | |
AT236975B (en) | Process for the preparation of new azidobenzenesulfonylureas | |
AT345301B (en) | PROCESS FOR THE PREPARATION OF NEW 4- (BETA-UREIDOAETHYL) -BENZENE SULFONYL UREA AND THEIR SALTS | |
AT353281B (en) | PROCESS FOR THE PREPARATION OF NEW 4- (BETA- -UREIDOAETHYL) -BENZENE-SULFONYL UREA AND THEIR SALTS | |
AT236974B (en) | Process for the preparation of new benzenesulfonylureas | |
CH442287A (en) | Process for the preparation of new benzenesulfonylureas | |
AT238215B (en) | Process for the preparation of new benzenesulfonylureas | |
CH374984A (en) | Process for the preparation of benzenesulfonylureas |